Welcome To The Alzheimer’s Solution

Ralph Sanchez image

Introducing BrainDefend®



A Personalized Body-Brain Health and
Renewal Program designed to protect
and optimize your cognitive health as you age. 


Latest News from the Blog
Lose The Belly Fat And Save Your Brain From Shrinking

Lose The Belly Fat And Save Your Brain From Shrinking

The role of obesity in late-onset Alzheimer’s disease is linked to insulin resistance, type 2 diabetes, cardiovascular disease, and chronic inflammation pathways. Not surprisingly, the same cardiometabolic disease patterns are correlated to brain and hippocampal volumes (brain shrinkage).

read more


Save Your Brain - Save Your Memories - Save Your Life
The Alzheimer's Solution Podcast image

The Alzheimer’s Solution Revolution Podcast


Think Ahead for a Better Brain Tomorrow!

MEMBER ACCESS: PFAS—The Little-Known Forever Chemicals are Emerging as Dangerous Neurotoxicants

A host of environmental toxins pose a significant health risk to the integrity of your brain (neurotoxins). Neurotoxins are ubiquitous and your exposures to many of them may be passing under your radar. This is especially true of a family ...
Read More

MEMBER ACCESS: Mercury Depletes Glutathione Peroxidase-Toxic Mechanisms In Alzheimer’s Disease Risk

The research demonstrating the deleterious and toxic effects of mercury on brain function and structure in neurodegenerative disease processes is plentiful. Adding to the research literature, a May/2009 study demonstrated that methylmercury* induces neurotoxicity, by significantly inactivating one the brain's ...
Read More
Image courtesy of the National Institute on Aging/National Institutes of Health

MEMBER ACCESS: Oxidative Stress and the Thromboxane Receptor—A Central Pivot in the Production of Neurofibrillary Tangles

New research published Oct. 13 (2014) by the journal Neurobiology of Aging revealed that the free radicals* produced during oxidative stress in Alzheimer's disease (AD) bind to a protein receptor in the brain designated as the: Thromboxane Receptor A2 (TP) ...
Read More

MEMBER ACCESS: TREM2 genetic variants in Alzheimer’s disease

Two recently published studies (2013) on a rare variant of the TREM2 gene (triggering receptor expressed on myeloid cells 2), designated as R47H, was shown to increase the risk of developing Alzheimer’s disease. Individuals with the variant may be up ...
Read More
Close up of blueberries clustered together

MEMBER ACCESS: Blueberry Polyphenols Protect the Brain from the Degenerative Processes Associated with Brain Aging and Alzheimer’s Disease

The study of plant and fruit polyphenols, a rich source of dietary antioxidants, represents one of the most promising areas of research in the field of anti-aging, and the prevention of degenerative disorders such as Alzheimer's disease. Recent and ongoing ...
Read More

MEMBER ACCESS: Brain-Derived Neurotrophic Factor—Growth Factors in Neurogenesis and the Protection Against Alzheimer’s Disease Progression

By Ralph Sanchez, MTCM, CNS, D.Hom. One of the longest held thoughts about damage to our brain's cells (neurons) was that once they were lost, it was a fait accompli. Damaged neurons were considered damaged goods, never to regain their ...
Read More

Join Us & Get MEMBER Access – it’s FREE!

#medicalfoods #cognitiveimpairment #alzheimersriskChanges on Fbook pages caused some confusion for me last week.This medical foods update was posted to my personal page last week and back here again!"Medical Foods and Nutraceuticals That Optimize Cognitive Function and Reduces the Risk for Late-Onset Alzheimer's disease." is the topic of episode #15 on The Alzheimers Solution Revolution podcast which you can access @podcasts.apple.com/.../the.../id1614865183The link to here is report on a proposed intervention study with a medical food—Souvenaid-Fortasnyn Connect® that will examine its potential benefits in "cognitively normal older individuals".Several studies and trials have evaluated the benefits of Souvenaid® and in a consensus opinion of those studies published in 2019 it was determined that there was improvement in memory and cognitive performance in patients with Mild Cognitive Impairment and early Alzheimer’s disease.Several analyses and clinical trials have shown benefits in memory and cognitive performance in patients with MCI and early Alzheimer’s disease as the 2019 consensus opinion analyses reported.Additionally, in the longest randomized clinical trial—3 years— in prodromal Alzheimer’s or MCI due to Alzheimer’s pathology—the LiPiDiDiet study, patients who were taking Souvenaid once daily for 3 years showed the following outcomes:• Slowed the progression of memory and cognitive decline by 60%• Reduced brain shrinkage by 33%• Reduced the loss of everyday task performance by 45%The LiPiDiDiet study conclusions were:“This multi-nutrient intervention slowed decline on clinical and other measures related to cognition, function, brain atrophy, and disease progression. These results indicate that intervention benefits increased with long‐term use.”Those findings were published in January of 2021.The above is a verbatim transcript of what I included in my podcast recently in which I also described two other medical foods that are FDA approved here in the U.S.Currently, Souvenaid-Fortasnyn Connect® is available in Australia, parts of Europe and Singapore.BrainDefend®www.medpagetoday.com/meetingcoverage/aaicvideopearls/100389Christian Camargo, MD, discusses the design of his feasibility study ... See MoreSee Less
View on Facebook



What a tremendous resource! Thank you for putting all of this great research in one place! I am also extremely interested in warding off a family history of Alzheimer’s and Dementia. Medicine can be so very powerful when we are able to identify the biochemical inefficiencies, apply specific dietary and nutritional remedies and compile a protocol to heal not just an individual, but generations. Thank you Ralph!

Tim Walsh LAc

This is an incredible article! Very powerful information! Thank you so much for putting it together the way that you have. This information needs to get out to the masses. You explained that very well.

Dr. Jones

Absolutely the BEST article I have read on the insulin/AD connection. As always, your brilliance is very much appreciated!

Kristin Rotblatt, L.Ac.

Thank you so much for this well written article. Looking forward to future updates. Thanks for this well illustrated, researched, and detailed yet succinct article.

Dr. Shah Roath


Pin It on Pinterest